BiotechTube
Home/AiViva BioPharma/Del Stagg, PhD
DS

Del Stagg, PhD

Vice President, Regulatory Affairs

AiViva BioPharma

Therapeutic Areas

DermatologyOphthalmologyOncologyUrology

AiViva BioPharma Pipeline

DrugIndicationPhase
AIV001 (axitinib)Nodular and Superficial Basal Cell Carcinoma (Nonmelanoma Skin Cancer)Phase 2

Leadership Team at AiViva BioPharma

DT
Diane Tang-Liu, PhD
President & Chief Executive Officer
DD
Darlene Deecher, PhD
Vice President, Clinical Development
AD
Agustin de la Calle, PhD
Vice President, Business Development
JW
Jinn Wu, PhD
Chairman of the Board
View full AiViva BioPharma profile